160 related articles for article (PubMed ID: 7737914)
1. Human alveolar macrophages augment natural killer cell stimulatory factor (interleukin-12)-inducible killer activity from autologous blood lymphocytes.
Haku T; Sone S; Nabioullin R; Ogura T
Jpn J Cancer Res; 1995 Jan; 86(1):81-7. PubMed ID: 7737914
[TBL] [Abstract][Full Text] [Related]
2. Induction mechanism of human blood CD8+ T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin-12).
Nabioullin R; Sone S; Nii A; Haku T; Ogura T
Jpn J Cancer Res; 1994 Aug; 85(8):853-61. PubMed ID: 7928632
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
4. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
D'Andrea A; Rengaraju M; Valiante NM; Chehimi J; Kubin M; Aste M; Chan SH; Kobayashi M; Young D; Nickbarg E
J Exp Med; 1992 Nov; 176(5):1387-98. PubMed ID: 1357073
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
D'Andrea A; Aste-Amezaga M; Valiante NM; Ma X; Kubin M; Trinchieri G
J Exp Med; 1993 Sep; 178(3):1041-8. PubMed ID: 8102388
[TBL] [Abstract][Full Text] [Related]
6. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
7. The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.
Doelker I; Anderer FA
Cancer Immunol Immunother; 1992; 34(5):299-305. PubMed ID: 1540976
[TBL] [Abstract][Full Text] [Related]
8. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Chong AS; Scuderi P; Grimes WJ; Hersh EM
J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
[TBL] [Abstract][Full Text] [Related]
9. Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cells.
Sone S; Utsugi T; Nii A; Ogura T
J Immunol; 1987 Jul; 139(1):29-34. PubMed ID: 3495601
[TBL] [Abstract][Full Text] [Related]
10. Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.
Nii A; Sone S; Utsugi T; Yanagawa H; Ogura T
Int J Cancer; 1988 Jan; 41(1):33-40. PubMed ID: 2826345
[TBL] [Abstract][Full Text] [Related]
11. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes.
Ogata K; Tamura H; Yokose N; An E; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Clark SC; Nomura T
Br J Haematol; 1995 May; 90(1):15-21. PubMed ID: 7786778
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Tripp CS; Wolf SF; Unanue ER
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3725-9. PubMed ID: 8097322
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of IL-7 and IL-12 on human T cell activation.
Mehrotra PT; Grant AJ; Siegel JP
J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1.
Sone S; Yanagawa H; Nishioka Y; Orino E; Bhaskaran G; Nii A; Mizuno K; Heike Y; Ogushi F; Ogura T
Eur Respir J; 1992 Feb; 5(2):174-81. PubMed ID: 1559582
[TBL] [Abstract][Full Text] [Related]
16. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
[TBL] [Abstract][Full Text] [Related]
17. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms.
Takeuchi E; Yanagawa H; Yano S; Haku T; Sone S
Jpn J Cancer Res; 1996 Dec; 87(12):1251-8. PubMed ID: 9045960
[TBL] [Abstract][Full Text] [Related]
18. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
Perussia B; Chan SH; D'Andrea A; Tsuji K; Santoli D; Pospisil M; Young D; Wolf SF; Trinchieri G
J Immunol; 1992 Dec; 149(11):3495-502. PubMed ID: 1358972
[TBL] [Abstract][Full Text] [Related]
19. Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophages.
Nii A; Sone S; Orino E; Ogura T
J Leukoc Biol; 1993 Jan; 53(1):29-36. PubMed ID: 8426089
[TBL] [Abstract][Full Text] [Related]
20. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
